Gang Liu

发表

Coumarin derivatives protect against ischemic brain injury in rats.

Dongmei Wang, Mingna Sun, Donghui Wu, 2013, European journal of medicinal chemistry.

IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells.

N. Chen, Dong-mei Wang, Mingna Sun, 2014, European journal of pharmacology.

The chemokine-like factor 1 induces asthmatic pathological change by activating nuclear factor-κB signaling pathway.

N. Chen, Zhen-zhen Wang, Dong-mei Wang, 2014, International immunopharmacology.

Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.

Dongmei Wang, Mingna Sun, Yun Zhang, 2010, Journal of medicinal chemistry.

Anti-inflammatory effect of IMMLG5521, a coumarin derivative, on Sephadex-induced lung inflammation in rats.

Shi-feng Chu, N. Chen, Mingna Sun, 2012, International immunopharmacology.

In vitro and in vivo anti-inflammatory effects of IMMLG5521, a coumarin derivative.

Mingna Sun, Zhipeng Li, Naihong Chen, 2013, International immunopharmacology.

IMM-H004, a novel coumarin derivative compound, attenuates the production of inflammatory mediatory mediators in lipopolysaccharide-activated BV2 microglia

N. Chen, Mingna Sun, Jin-feng Hu, 2014, Brain Research Bulletin.

Effect of compound IMMLG5521, a novel coumarin derivative, on carrageenan-induced pleurisy in rats.

N. Chen, Mingna Sun, Jin-feng Hu, 2011, European journal of pharmacology.

Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264.7 macrophages

Gang Liu, Gang Liu, Geng-tao Liu, 2009, Acta Pharmacologica Sinica.